Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ImClone and Bristol-Myers expand Erbitux codevelopment agreement

July 31, 2007

Osiris and Genzyme to codevelop Prochymal for ARS

July 31, 2007

Patient treatment begins in phase I/II trial of MDV-3100 in hormone-refractory prostate cancer

July 30, 2007

Cell Therapeutics acquires Systems Medicine; gains worldwide rights to brostallicin

July 27, 2007

ODAC recommends FDA waits for survival results of phase III satraplatin trial

July 27, 2007

Revlimid launched in U.K.

July 27, 2007

Switzerland approves Tasigna based on efficacy in CML patients nonresponsive to Glivec

July 27, 2007

BioLineRx and University of Illinois to develop cancer apoptosis agent

July 27, 2007

Oncolytics enrolls patients in U.K. combination clinical trial of Reolysin/docetaxel

July 27, 2007

EntreMed commences leukemia clinical trial for MKC-1

July 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...